Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,284 | 268,678 | 3,410 | N/A | N/A |
| Marketable Securities | 138,056 | N/A | N/A | N/A | N/A |
| TOTAL | $200,402 | $275,259 | $3,604 | $N/A | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 219 | 0 | 0 | 0 | 0 |
| TOTAL | $219 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $200,621 | $275,259 | $3,604 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,929 | 2,385 | 1,394 | 0 | 0 |
| Accrued Expenses | 15,496 | 6,580 | 408 | N/A | N/A |
| Other current liabilities | N/A | N/A | 14,808 | N/A | N/A |
| TOTAL | $20,425 | $8,965 | $16,610 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $20,425 | $8,965 | $16,610 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,717 | 62,379 | N/A | N/A | N/A |
| Common Shares | 6 | 6 | N/A | N/A | N/A |
| Retained earnings | -148,158 | -51,524 | -13,006 | N/A | N/A |
| Other shareholders' equity | -24 | 0 | 0 | 0 | 0 |
| TOTAL | $180,196 | $266,294 | $-13,006 | $N/A | $N/A |
| Total Liabilities And Equity | $200,621 | $275,259 | $3,604 | $0 | $0 |